Source: Eur Respir J 2014; 43: 1298-1305
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kon Samantha S.C., Canavan Jane L., Nolan Claire M., Clark Amy L., Jones Sarah E., Cullinan Paul, Polkey Michael I., Man William D-C.. The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference. Eur Respir J 2014; 43: 1298-1305

Member's Comments

No comment yet.

Related content which might interest you: What is the minimum clinically important difference in the incremental shuttle walking test (ISWT) observed in pulmonary rehabilitation? Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002 Minimal clinically important difference in 30 second sit-to-stand test after pulmonary rehabilitation in patients with COPD Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content Year: 2018 3-minute constant-rate shuttle walking (3MWT) and stair stepping tests (3MST) to assess exertional breathlessness in COPD: responsiveness to pulmonary rehabilitation and estimation of the minimal important difference Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both? Source: Eur Respir J 2016; 48: 315-319 Year: 2016 Bone health of patients with COPD in relation to their exercise capacity and gait speed Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 The incremental shuttle walk test (ISW) in patients with bronchiectasis: Response to pulmonary rehabilitation (PR) and minimum clinically important difference (MCID) Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 What the 4-metre gait speed measures and why it cannot replace functional capacity tests Source: Eur Respir J 2014; 43: 1820-1822 Year: 2014 The minimal important difference in treadmill endurance test in COPD patients after a comprehensive pulmonary rehabilitation program (PRP) Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011 What the 4-metre gait speed measures and why it cannot replace functional capacity tests Source: Eur Respir J 2014; 43: 1819-1820 Year: 2014 LATE-BREAKING ABSTRACT: The minimal clinically important difference (MCID) for the six minute walk (6MW) test in COPD in relation to death Source: Annual Congress 2012 - The latest insights in chronic care Year: 2012 The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004 The relationship of results of sit-to-stand test with exercise capacity and quality of life in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 632s Year: 2004 The impact of body composition on walking distance in the six-minute walk test in COPD patients Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Clinical relevance of constant power exercise duration changes in COPD Source: Eur Respir J 2009; 33: 340-345 Year: 2009 Does loss of automaticity influence dual task cost walking velocity in COPD patients? Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 Evaluating impairment in exercise capacity in COPD patients with the six-minute walk distance test: a comparative study Source: Eur Respir J 2006; 28: Suppl. 50, 767s Year: 2006 The relationship among 6-minute walk test performance, respiratory muscles, ventilatory parameters and dyspnoea severity in long COVID patients: Preliminary results. Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 Test-retest reliability, minimal detectable change and minimal clinically important differences in the modified shuttle walk test in children and adolescents with cystic fibrosis Source: Virtual Congress 2020 – Clinical year in review Year: 2020 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 A single dose of tiotropium produces a significant improvement in 6-minute walk distance in severe COPD subjects Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005